Swedish Orphan Biovitrum AB (SWOBY)
24.31
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Swedish Orphan Biovitrum Price to Book Value : 3.867 for Aug. 26, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 26, 2026 | 3.867 |
| August 25, 2026 | 3.867 |
| August 24, 2026 | 3.867 |
| August 21, 2026 | 3.867 |
| August 20, 2026 | 3.867 |
| August 19, 2026 | 3.867 |
| August 18, 2026 | 3.867 |
| August 17, 2026 | 3.867 |
| August 14, 2026 | 3.867 |
| August 13, 2026 | 3.867 |
| August 12, 2026 | 3.867 |
| August 11, 2026 | 3.867 |
| August 10, 2026 | 3.867 |
| August 07, 2026 | 3.867 |
| August 06, 2026 | 3.698 |
| August 05, 2026 | 3.698 |
| August 04, 2026 | 3.698 |
| August 03, 2026 | 3.714 |
| July 31, 2026 | 3.714 |
| July 30, 2026 | 3.738 |
| July 29, 2026 | 3.738 |
| July 28, 2026 | 3.738 |
| July 27, 2026 | 3.738 |
| July 24, 2026 | 3.738 |
| July 23, 2026 | 3.977 |
| Date | Value |
|---|---|
| July 22, 2026 | 3.977 |
| July 21, 2026 | 3.977 |
| July 20, 2026 | 3.977 |
| July 17, 2026 | 3.977 |
| July 16, 2026 | 3.977 |
| July 15, 2026 | 3.977 |
| July 14, 2026 | 3.977 |
| July 13, 2026 | 3.977 |
| July 10, 2026 | 3.977 |
| July 09, 2026 | 3.977 |
| July 08, 2026 | 3.977 |
| July 07, 2026 | 3.977 |
| July 06, 2026 | 3.977 |
| July 02, 2026 | 4.136 |
| July 01, 2026 | 3.819 |
| June 30, 2026 | 3.763 |
| June 29, 2026 | 3.753 |
| June 26, 2026 | 3.949 |
| June 25, 2026 | 3.926 |
| June 24, 2026 | 3.783 |
| June 23, 2026 | 3.783 |
| June 22, 2026 | 3.786 |
| June 18, 2026 | 3.786 |
| June 17, 2026 | 3.786 |
| June 16, 2026 | 3.800 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Hansa Biopharma AB | -- |
| BioArctic AB | 12.22 |
| Diamyd Medical AB | 4.027 |
| BONESUPPORT HOLDING AB | 15.68 |
| BioInvent International AB | 4.695 |
Price to Book Value Related Metrics
| PE Ratio | 112.29 |
| PS Ratio | 5.174 |
| Price to Free Cash Flow | 34.05 |
| Price | 24.31 |
| Earnings Yield | 0.89% |
| Market Cap | 16.89B |
| Operating PE Ratio | 17.20 |
| Normalized PE Ratio | 24.41 |